Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

377 studies match

clinicaltrialsPublishedShowing 51–100 of 377 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07150104	Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM	active not recruiting	Phase 1 / Phase 2	14	GlaxoSmithKlineINDUSTRY	8	Jun 25, 2026	clinicaltrials
NCT07217184	Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM	active not recruiting	Phase 1 / Phase 2	30	GlaxoSmithKlineINDUSTRY	11	Jun 25, 2026